Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

S&P Spin-Off Invesco ETF (NY: CSD )

89.24 +2.59 (+2.98%)
Official Closing Price Updated: 8:00 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about S&P Spin-Off Invesco ETF

Kyndryl, Dell, Nvidia Join Forces To Launch AI Private Cloud For Japanese Enterprises
Kyndryl Holdings shares are trading higher after the company launched a dedicated AI private cloud in Japan. 
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
GE HealthCare And DeepHealth Team Up To Advance AI-Powered Breast Cancer Screening: Details
GE HealthCare and DeepHealth collaborate to develop AI-powered solutions for imaging, starting with breast cancer screening. 
Via Benzinga
GE Vernova Gains Investor Confidence With Strong Revenue Outlook And Path To Higher Margins, Say Analysts
GEV share price rises on strong earnings, with analysts optimistic about future revenue and margins. Morgan Stanley raises PT to $301, RBC raises PT to $285, and Oppenheimer remains cautious. 
Via Benzinga
GE Vernova Set For $2.5B Free Cash Flow By 2026 Amid Energy Transition Boom, Bullish Analyst Says
Analyst initiates coverage on GEV with Buy rating and $300 price target, citing strong position in energy transition and growth potential. 
Via Benzinga
GE Vernova's Gas Power Services Underappreciated & Poised For Growth: Analyst
GE Vernova upgraded to Buy by BofA Securities, price target raised from $200 to $300. Analyst sees potential in Gas Power Services. 
Via Benzinga
GXO Logistics Q2: Revenue Gains Offset By Profit Margin Squeeze
GXO Logistics beats revenue consensus with $2.85B in Q2. Organic revenue rose 2%, new business wins add $270M. FY24 outlook reaffirmed. 
Via Benzinga
GE HealthCare Taps AWS for Groundbreaking AI Medical Solutions: Details
GEHC and AWS partner to advance healthcare through specialized foundation models and generative AI apps, using AWS' cloud and AI services. 
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
What's Going On With GE Vernova Shares Today?
GE Vernova has secured a major order from Sonelgaz through their joint venture, GE Algeria Turbines, to enhance Algeria's grid infrastructure. 
Via Benzinga
GXO Logistics Deploys Robotics Solution For Sporting Goods Retailer In France
GXO Logistics implements robotics solution for a global sporting goods retailer in France, streamlining order processing and enhancing adaptability in logistics. 
Via Benzinga
Tap Into Trends: 3 Thematic ETFs to Capture the Market’s Pulse
Invest smarter with Wall Street's exchange-traded funds and seize market momentum with these thematic ETFs to buy. 
Via InvestorPlace
Topics ETFs
Why Carrier Global Shares Are Surging Today
Carrier Global shares are trading higher on Q1 FY24 results, with net sales and adjusted EPS beating consensus. Company also revises sales outlook and expects to resume share repurchases in 2024. 
Via Benzinga
Why Apartment Income REIT Shares Are Rocketing Today
Blackstone is acquiring Apartment Income REIT Corp. for $10 billion. The deal will take AIR Communities private and suspend dividends. 
Via Benzinga
Radiopharmaceuticals Startup RayzeBio Seeks Public Debut After Raising $400M From Investors
RayzeBio Inc, a San Diego company focused on radiopharmaceutical therapies for cancer, filed on Thursday to raise up to $1 
Via Benzinga
Healthcare Software Firm Waystar Goes IPO Way With Potential $8B Valuation
Waystar Inc, a provider of financial management software for hospitals and medical practices, is reportedly making strides toward an initial public offering (IPO) that could value the company up to $8... 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
Second Time Charm: Sagimet Biosciences Seeks Public Debut With $75M IPO
On Friday, Sagimet Biosciences, a clinical-stage biopharmaceutical company, filed with the SEC to raise up to $75 million in an initial public off 
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.